Clinical Trials Browser

Phase 1 × INDUSTRY × von Hippel-Lindau Disease × Clear all

NCT04895748 2026-03-03

DFF332 as a Single Agent and in Combination With Everolimus & Immuno-Oncology Agents in Advanced/Relapsed Renal Cancer & Other Malignancies

Phase 1 Terminated

CNSEndocrineGenitourinary

Hereditary leiomyomatosis and renal cell cancer, Carcinoma, Renal Cell, von Hippel-Lindau Disease, Paraganglioma, Pheochromocytoma

NCT06553339 2024-08-14

A Study of HS-10516 in Patients With VHL Syndrome Associated Tumors

Phase 1 Recruiting

von Hippel-Lindau Disease, Neuroectodermal Tumors, Primitive

NCT05843305 2023-05-06

A Study of BPI-452080 in Subjects With Solid Tumors

Phase 1 Unknown

Carcinoma, Renal Cell, von Hippel-Lindau Disease